Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China flag China · Delayed Price · Currency is CNY
19.74
-0.24 (-1.20%)
Aug 14, 2025, 2:45 PM CST
-1.20%
Market Cap16.50B
Revenue (ttm)4.05B
Net Income (ttm)704.05M
Shares Out825.93M
EPS (ttm)0.83
PE Ratio24.06
Forward PE20.28
Dividend0.35 (1.75%)
Ex-Dividend DateMay 29, 2025
Volume25,230,316
Average Volume37,853,686
Open18.80
Previous Close19.98
Day's Range18.80 - 20.34
52-Week Range10.50 - 20.58
Beta-0.14
RSI79.62
Earnings DateAug 27, 2025

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat... [Read more]

Sector Healthcare
Founded 1990
Employees 3,869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002020
Full Company Profile

Financial Performance

In 2024, SHE:002020's revenue was 4.16 billion, an increase of 3.99% compared to the previous year's 4.00 billion. Earnings were 711.96 million, an increase of 15.04%.

Financial Statements

News

There is no news available yet.